Product record
Pioglitazone Glimepiride + Metformin: batches declared Not of Standard Quality
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts, Jan 2019, Jul 2026
1 batch of products named "Pioglitazone Glimepiride + Metformin" (as printed by the testing lab) failed a CDSCO or state drug-testing laboratory test between February 2025 and February 2025. This is a record of specific batches, it does not mean the molecule or every brand is unsafe.
Records by type
1 record linked to Pioglitazone Glimepiride + Metformin in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A failed batch is not a verdict on every pack of this product. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches
| Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| SP/T/74 3Mfg ? · Exp ? | Signoret Pharmaceuticals Pvt.Ltd | For the received sample PIOGLITAZONE 15, GLIMEPIRIDE 2mg+ METFORMIN 500 mg (Lanzpride-PM2), 1. The label is mentioned as ?Approved colour used? but common name of the permitted colour used in the formulation as prescribed under rule 127(2) of the Drugs Rules,1945 was not mentioned. 2.For the received sample PIOGLITAZONE 15, GLIMEPIRIDE 2mg+ METFORMIN 500 mg (Lanzpride-PM2), On visual inspection pink coloured spots were observed on other side (white colour) of the tablets .-MisbrandedMisbranded | PuducherryState lab | Feb 2025 |
How to use this. Match the batch number on your strip or bottle against the list. If your batch is listed, return it to the pharmacy and ask for a replacement; if not, the product is not on any alert as of July 2026. Check any batch number.